Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication ...
Aug 15, 2023
0
27
COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease.
Dec 30, 2022
0
94
Dozens of people in China have fallen ill with a new virus that is also found in shrews, a report has said, but there is so far no evidence of human-to-human transmission.
Aug 11, 2022
2
86
New research shows that an experimental drug fine-tuned to a specific pain pathway can ease post-surgery aches, a finding that may eventually offer an alternative to highly addictive opioids.
Aug 3, 2023
0
38
A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children's Oncology Group (COG) and led ...
Nov 3, 2022
0
35
A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect health care workers against COVID-19.
Apr 26, 2023
0
37
Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As Albino Oliveira-Maia, head of the Champalimaud Foundation's Neuropsychiatry Unit and the study's national coordinator ...
Oct 4, 2023
0
77
A single-dose of the antiviral drug peginterferon lambda reduced by half the risk of hospitalization or a visit to the Emergency Department due to COVID-19, according to a study published today in the New England Journal ...
Feb 8, 2023
0
123
A Vanderbilt University Medical Center-led study comparing the two types of laryngoscopes used in tracheal intubation of critically ill patients showed that the use of a video laryngoscope increased successful intubation ...
Jun 16, 2023
0
68
"How do you feel about black licorice?" sounds like a question for starting a simple chat at a Halloween party—or a silly internet fight. It's a love-it-or-hate-it candy that inspires intense opinions.
Oct 28, 2022
0
52
